Cancer drug payment nudges Sareum Holdings (SAR.L) into maiden profit: ProactiveInvestors Stocktube

ProactiveInvestors Stocktube

Published on 20 Feb 2017

Tim Mitchell, chief executive of Sareum Holdings Plc (LON:SAR) tells Proactive the company's posted a maiden profit after receiving the first payments from licensing lead product, a Chk1 inhibitor cancer candidate, to Sierra Oncology.